A U.K. study in Nature Genetics found that the KLF14 gene, previously linked to type 2 diabetes and cholesterol levels, acts as a main control for genes associated with obesity, insulin and glucose levels and other metabolic traits. Experts said targeting the KLF14 gene could help improve treatments for obesity-related conditions, including diabetes and cardiovascular diseases.

Full Story:

Related Summaries